Diversified Trust CO Neurocrine Biosciences Inc Transaction History

Diversified Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 08, 2024	BUY	$106.07 - $132.76 $28,320 - $35,446	267 Added 12.63%	2,381 $313,000
Q3 2023 Nov 17, 2023	BUY	$94.02 - $117.1 $198,758 - $247,549	2,114 New	2,114 $237,000
Q1 2023 Apr 07, 2023	BUY	$94.11 - $123.02 $13,457 - $17,591	143 Added 6.58%	2,316 $234,000
Q4 2022 Jan 17, 2023	SELL	$106.72 - $127.06 $6,830 - $8,131	-64 Reduced 2.86%	2,173 $260,000
Q3 2022 Oct 14, 2022	BUY	$92.03 - $107.81 $205,871 - $241,170	2,237 New	2,237 $238,000

638

93.8M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14.5B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

Stay updated on Diversified Trust CO with notifications on news.